Daily Essential Supplements by VāyasLife Even a reasonably balanced diet can leave...
Turning 30 does not suddenly change your fertility overnight. There is no switch that gets flipped on your 30th birthday.
What does happen is more gradual. As women get older, the number of eggs remaining in the ovaries comes down, and the quality of those eggs also begins to change. Fertility starts declining in the early 30s and the decline becomes more noticeable through the mid-30s. That is simply part of ovarian ageing, not a reason to panic the moment you cross 30.
This is also why conversations around fertility after 30 increasingly include something called Coenzyme Q10, or CoQ10.
CoQ10 is not a fertility hormone and it cannot give you more eggs. It is a substance already present in the body that helps our cells produce energy. That becomes interesting because an egg is an extremely energy-hungry cell. It needs energy to mature properly, be fertilised and support the first stages of embryo development.
Researchers have therefore been asking a fairly logical question: if CoQ10 helps cells produce energy, could taking additional CoQ10 help support ageing egg cells and, in turn, female fertility?
The answer so far is encouraging, although it needs some context.
Studies in women with reduced ovarian reserve and women undergoing IVF have reported improvements in things such as the number of mature eggs retrieved, fertilisation and embryo development. Some studies have also found higher pregnancy rates. What we do not yet have is strong proof that every woman over 30 who takes CoQ10 will improve her egg quality or become more likely to conceive naturally.
So rather than treating CoQ10 as another “fertility supplement you should take after 30,” it is worth looking at what actually changes in female fertility with age, why CoQ10 is being studied, and what the human research has found.
The first thing to get out of the way is the idea that fertility suddenly drops the moment you turn 30. It does not.
What changes is more gradual. Women are born with a finite number of eggs, and that number falls steadily over time. At the same time, the eggs that remain become more likely to develop chromosome errors as we get older. That is one of the main reasons fertility declines with age and the risk of miscarriage rises, particularly from the mid-30s onward.
That does not mean a woman in her early 30s should assume she will have difficulty conceiving. Plenty of women conceive naturally in their 30s. Age is simply one factor that becomes increasingly important as the years pass.
There are really two things changing together: egg quantity and egg quality.
Egg quantity is easier to understand. The ovarian reserve gradually becomes smaller with age.
Egg quality is a little harder to define. In fertility medicine, it broadly refers to whether an egg has the ability to mature normally, be fertilised and eventually contribute to a healthy embryo and pregnancy. There is no simple blood test that tells you, “Your egg quality is 80%.” Even ovarian-reserve tests such as AMH mainly tell doctors about the number of eggs available and how the ovaries may respond to stimulation, rather than directly measuring the quality of those eggs.
One of the reasons egg quality becomes more vulnerable with age is that chromosome separation during egg maturation becomes less reliable. Eggs with the wrong number of chromosomes are more likely to fail to fertilise normally, stop developing, fail to implant or result in miscarriage.
There is another part of this story that has become especially interesting to fertility researchers: the way ageing affects the energy machinery inside the egg.
And that is where CoQ10 starts to become relevant.
This is where the CoQ10 story starts to make sense.
An egg is not simply sitting quietly in the ovary waiting to be fertilised. Once it begins maturing, it has a lot of work to do. It has to complete its own maturation, organise its chromosomes correctly, respond to fertilisation and then support the first stages of embryo development. All of that takes energy.
Most of this energy comes from tiny structures inside the egg called mitochondria. You can think of them as the cell’s energy-producing units. Eggs contain a particularly large number of mitochondria because their energy demands are so high.
As women get older, these mitochondria can become less efficient. Ovarian ageing has been linked to poorer mitochondrial function with reduced egg quality, problems with chromosome organisation and poorer embryo development.
This does not mean that every fertility problem after 30 is caused by tired mitochondria. Ageing of the egg is much more complicated than that. But mitochondrial health appears to be one meaningful part of the picture.
And that matters for CoQ10 because CoQ10 helps mitochondria produce energy. It also helps protect cells against oxidative stress.
So when researchers started looking for ways to support ageing egg cells, CoQ10 became an obvious nutrient to investigate.
The interesting question now is whether giving additional CoQ10 actually makes a difference in women, not just whether the biology sounds convincing.
That is what we will look at next.
CoQ10 is already made naturally in the body. One of its main jobs is helping mitochondria produce energy, which is exactly why fertility researchers became interested in it.
There is also another reason. CoQ10 works as an antioxidant, so it may help protect cells from oxidative stress. Since ageing egg cells tend to show both weaker mitochondrial function and more oxidative damage, CoQ10 seems like a sensible nutrient to study in this context.
Some of the early research was done in animals, and it was quite striking. In one widely cited study, older female mice had lower CoQ10-related activity in their eggs, poorer mitochondrial function and lower energy production. When the animals were given CoQ10, several age-related problems in the eggs improved.
That does not mean we can take an animal study and say the same thing will happen in every woman. But it gave researchers a strong reason to test CoQ10 in human fertility treatment.
And that is where the story gets more interesting.
Human studies have since looked at CoQ10 in women with diminished ovarian reserve, older women undergoing IVF, and women who respond poorly to ovarian stimulation. Some of those trials have reported better egg retrieval, fertilisation and embryo-related outcomes, although the evidence is not equally strong for every endpoint. A review looking specifically at CoQ10 and human egg quality concluded that the biology is promising, but the clinical evidence still needs to be interpreted carefully.
This is where we need to be a little careful with the phrase “egg quality,” because it gets used very loosely online.
There is no simple test that tells you whether an egg is “good” or “bad.” In fertility research, doctors usually look at practical outcomes around the egg: how many mature eggs are retrieved, whether they fertilise, how well the resulting embryos develop, and whether pregnancy follows.
One of the more useful human studies looked at women under 35 who had diminished ovarian reserve and were preparing for IVF or ICSI. The women who received CoQ10 for 60 days before treatment had more eggs retrieved, better fertilisation rates and more high-quality embryos than the women who did not take CoQ10.
That is encouraging because it moves the conversation beyond theory. Researchers were not just measuring CoQ10 levels or laboratory markers. They were looking at actual reproductive outcomes.
A larger 2024 review brought together six randomised trials involving more than 1,500 women with diminished ovarian reserve. Overall, CoQ10 pretreatment was associated with more eggs retrieved, more optimal embryos, fewer cancelled treatment cycles and higher clinical pregnancy rates.
So when people say CoQ10 may support egg quality, there is some real human evidence behind that idea.
But I would still avoid turning that into a blanket statement like “CoQ10 improves egg quality in every woman after 30.”
Most of the stronger studies have been done in women who already had reduced ovarian reserve or were undergoing fertility treatment. That is very different from a healthy 31-year-old who has just started trying to conceive naturally.
A more accurate way to put it is this: CoQ10 has shown encouraging effects on egg and embryo-related outcomes in women with fertility challenges, especially those with diminished ovarian reserve.
That is promising, but it is not the same as a guarantee.
This is where the age question becomes more relevant. As women move through their mid-30s and beyond, the chance of chromosome errors in eggs increases. That is one of the reasons fertility begins to decline more noticeably with age.
Researchers have specifically looked at whether CoQ10 might help here.
In one randomized, placebo-controlled study, women aged 35 to 43 who were undergoing IVF or ICSI were given 600 mg of CoQ10 daily or a placebo. The researchers then looked at chromosome abnormalities in the eggs.
The results were encouraging, but not conclusive. The proportion of eggs with chromosome abnormalities was 46.5% in the CoQ10 group compared with 62.8% in the placebo group. Clinical pregnancy rates were also slightly higher with CoQ10.
At first glance, that looks impressive.
The problem is that the study had to be stopped early and ended up with too few participants to prove that the difference was statistically significant. So we cannot say that CoQ10 prevents age-related chromosome problems in eggs.
Still, the study is useful because it looked directly at women in the age group we are talking about and at one of the major reasons fertility becomes harder with age.
So for women over 35, CoQ10 remains interesting. The research suggests a possible benefit, but the evidence is not strong enough to say that it can reverse ovarian ageing or protect every egg from age-related changes.
This is where the evidence for CoQ10 becomes a little stronger, because most of the human research has been done in women who were already undergoing fertility treatment.
A 2020 review combined five randomised trials involving 449 women having assisted reproductive treatment. The women who took CoQ10 had a higher clinical pregnancy rate than those who took a placebo or no CoQ10: about 29% versus 14%. That sounds encouraging, and it is. But there is an important distinction. The same review did not find a clear improvement in live-birth rates.
In simple terms, more women in the CoQ10 groups became clinically pregnant, but the research was not strong enough to show that this translated into more babies being born.
A larger 2024 review focused specifically on women with diminished ovarian reserve undergoing IVF or ICSI. It brought together six randomised trials involving 1,529 women. CoQ10 pretreatment was linked with more eggs retrieved, more good-quality embryos, fewer cancelled cycles and higher clinical pregnancy rates.
A newer 2026 trial adds to the same picture. In women who were known to respond poorly to ovarian stimulation, CoQ10 improved the number of eggs retrieved and some embryo-related outcomes. But once again, pregnancy rates themselves were not significantly different.
So there is a pattern emerging.
CoQ10 seems most consistently promising for the earlier stages of fertility treatment: how the ovaries respond, how many eggs are retrieved, and how well embryos develop. The evidence becomes less certain when we move to the outcome that matters most, which is a successful live birth.
That does not make the earlier findings unimportant. It simply tells us where the science is strongest today.
CoQ10 is interesting because there is more behind it than the usual “fertility supplement” claim.
We know that egg cells need a great deal of energy, that mitochondrial function becomes less efficient as eggs age, and that CoQ10 has an important role in helping those mitochondria produce energy. More importantly, human studies have now found encouraging results in women with diminished ovarian reserve and women undergoing IVF or ICSI, including more eggs retrieved, better fertilisation and embryo-related outcomes, and higher clinical pregnancy rates in some studies.
What the research does not tell us is that every woman should start CoQ10 as soon as she turns 30. It also does not prove that CoQ10 can reverse ovarian ageing, guarantee better egg quality or increase the chances of natural conception in every woman.
That distinction matters.
A healthy woman in her early 30s who has just started trying for a baby is in a very different situation from a woman in her late 30s with diminished ovarian reserve or someone preparing for IVF. Age, ovarian reserve, how long you have been trying to conceive and your overall fertility picture all influence whether adding a supplement makes sense.
If CoQ10 is something you are considering, Vāyas Life also offers a standalone CoQ10 supplement, which keeps things simple if you specifically want to add CoQ10 rather than take a multi-ingredient fertility blend. If you are already undergoing fertility treatment or actively trying to conceive, it is worth discussing supplementation with your doctor so it fits into the larger plan.
Perhaps the most useful way to look at CoQ10 after 30 is this: it cannot stop the clock, but the research suggests that it may support some of the cellular processes that become increasingly important as eggs age.
And that makes it worth a conversation, without turning it into a promise.
